Hemodynamic Monitoring Systems Market

Hemodynamic Monitoring Systems Market Poised to Account for US$ 508.4 Mn by the End
of 2021
Persistence Market Research (PMR), in a recent report, “Global Market Study on Hemodynamic
Monitoring System: Growing Demand for Critical Congenital Heart Disease Screening to Drive the
Market by 2021 ”, projected the hemodynamic monitoring systems market to expand at a healthy
CAGR of 6.5% during the forecast period. The report offered trends driving the market and
delivered analysis and insights on the potential of the hemodynamic monitoring systems market in
specific regions.
In terms of revenue, the hemodynamic monitoring systems market was valued at US$ 328.7 Mn in
2014 and is projected to reach US$ 508.4 Mn by 2021. Factors driving market growth include
government and private sector initiatives to reduce healthcare costs, rising prevalence of lifestyle
diseases, growing the geriatric patient population, increasing the incidence of respiratory disorders
and growing demand for the screening of critical congenital heart disease (CCHD).
Request to view table of content @ https://www.persistencemarketresearch.com/toc/4396
In terms of region, North America dominated the hemodynamic monitoring systems market with
over 30% share in terms of value in 2014 but is expected to lose its market share to APAC by 2021.
Europe accounted for over 20% of the total hemodynamic monitoring systems market share in 2014
and will maintain its dominance through 2021. Among the regions, APAC is projected to register
the highest CAGR over 2015–2021 due to low-cost product offerings by manufacturers in the
region. As of 2014, APAC was the third-highest contributor to the overall hemodynamic monitoring
systems market, accounting for over 18% market share. By the end of 2021, it is projected to gain
330 BPS.
On the basis of device type, the market has been segmented into pulse contour, oesophageal
Doppler, volume clamp, hemodynamic monitoring sensors and pulmonary artery catheters.The
pulmonary artery catheters segment had a dominant share in the global hemodynamic monitoring
systems market in 2014, while the volume clamp segment accounted for over 20% share.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/4396
Global hemodynamic monitoring systems market is further segmented on the basis of end use into
hospitals, clinics, ambulatory surgery centres, home care settings and independent catheterisation
laboratories. Revenue contribution of the hospitals segment was over 40% in 2014 and is projected
to increase to over 42% by 2021, registering a significant CAGR of 7.3%. Home care settings
segment is anticipated to record highest CAGR during the forecast period as hemodynamic
monitoring systems are being adopted increasingly in home care settings.
By application type, the hemodynamic monitoring systems market is segmented into invasive
hemodynamic monitoring, noninvasive hemodynamic monitoring and minimally invasive
hemodynamic monitoring segments. Among the three segments, minimally invasive hemodynamic
monitoring segment is expected to register the highest CAGR of 8.0% over 2015-2021. The
invasive hemodynamic monitoring segment accounted for over 30% market share in 2014 but is
projected to lose its share to the other two segments by the end of the forecast period.
Key players in the global hemodynamic monitoring systems market include Edwards Lifesciences
Corporation, ICU Medical, Inc., Teleflex Incorporated, LiDCO Group Plc and PULSION Medical
Systems SE. Global players focus on research and development initiatives for introducing
innovative products to attain sustainable advantages over their competitors. In addition, they also
focus on expanding their regional presence through mergers and acquisitions. In developed regions,
hemodynamic monitoring systems manufacturers prefer selling their products directly to the
consumer. By contrast, most vendors in countries such as China have tie-ups with suppliers to
enhance their customer reach. Globally, medical equipment manufacturers in China account for
over 50% market share for exporting noninvasive devices.
Buy Hemodynamic Monitoring System Market Report @